Balyasny Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Balyasny Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-457,697	Closed	-$99.3M	–	2632
2021 Q1	$99.3M	Buy	+457,697	New	+$86M	0.49%	27
2020 Q3	–	Sell	-26,407	Closed	-$3.24M	–	1709
2020 Q2	$3.24M	Sell	26,407 -8,061	-23%	-$915K	0.03%	618
2020 Q1	$3.02M	Buy	34,468 +30,179	+704%	+$3.2M	0.04%	518
2019 Q4	$448K	Sell	4,289 -68,051	-94%	-$7.63M	﹤0.01%	1013
2019 Q3	$8.32M	Buy	+72,340	New	+$11M	0.06%	446
2019 Q2	–	Sell	-126,439	Closed	-$21.9M	–	1822
2019 Q1	$21.3M	Buy	126,439 +110,224	+680%	+$16.4M	0.14%	213
2018 Q4	$1.58M	Buy	+16,215	New	+$2.13M	0.01%	772
2017 Q4	–	Sell	-90,474	Closed	-$9.18M	–	2431
2017 Q3	$9.18M	Buy	+90,474	New	+$9.69M	0.04%	533
2017 Q2	–	Sell	-5,500	Closed	-$665K	–	1860
2017 Q1	$665K	Buy	+5,500	New	+$675K	﹤0.01%	1232

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Balyasny Asset Management's GWPH Position: Q2 2021 in Review

Balyasny Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 457,697 shares — an estimated $99.3M sold.

Balyasny Asset Management first reported a position in GWPH in Q1 2017 and held it in 9 quarters. The position peaked at $99.3M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Balyasny Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Balyasny Asset Management sold 457,697 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $99.3M.
Balyasny Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2017 and held it in 9 quarters.
Balyasny Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $99.3M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Balyasny Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.